Coronary artery disease (CAD) refers to a group of diseases caused by narrowing of the coronary arteries due to atherosclerosis. It includes conditions like stable angina, unstable angina, myocardial infarction, and sudden cardiac death. A survey found that residents of public housing in Charlotte had several risk factors for CAD such as high blood pressure, high cholesterol, diabetes, and smoking. Diagnosis involves tests like ECG, cardiac markers, stress echocardiography, and coronary angiography. Treatment includes lifestyle changes, medications, angioplasty, stents, and coronary artery bypass grafting. Nursing management focuses on pre-procedure teaching, post-procedure monitoring for bleeding or other complications, and managing post-surgical
Coronary artery disease or Ischemic heart disease ANILKUMAR BR
Cardiovascular disease are becoming a leading cause of morbidity and mortality in developed countries and they are also emerging as prominent national health problem in developing countries.
Coronary artery disease has become the major cause of early death and disability in the population.
Coronary artery disease (CAD) can also be used interchangeably with the terms atherosclerotic heart disease or ischemic heart disease.
All of these terms imply insufficient perfusion of the coronary arteries from an abnormal narrowing of the vessels, leading to insufficient oxygen delivery to the myocardial tissue.
The term coronary heart disease, also known as coronary artery disease or Ischemic heart disease, is a condition refers to diseases of the heart that result from a decrease in blood supply to the heart muscle.
Non modifiable risk factors
Modifiable risk factors
Contributing risk factors
Coronary artery disease or Ischemic heart disease ANILKUMAR BR
Cardiovascular disease are becoming a leading cause of morbidity and mortality in developed countries and they are also emerging as prominent national health problem in developing countries.
Coronary artery disease has become the major cause of early death and disability in the population.
Coronary artery disease (CAD) can also be used interchangeably with the terms atherosclerotic heart disease or ischemic heart disease.
All of these terms imply insufficient perfusion of the coronary arteries from an abnormal narrowing of the vessels, leading to insufficient oxygen delivery to the myocardial tissue.
The term coronary heart disease, also known as coronary artery disease or Ischemic heart disease, is a condition refers to diseases of the heart that result from a decrease in blood supply to the heart muscle.
Non modifiable risk factors
Modifiable risk factors
Contributing risk factors
Cardiogenic shock is a rare condition .in this heart unable to pump an adequate amount of blood flow. types coronary cardiogenic shock and noncoronary cardiogenic shock.causes include any rupture of the in the ventricles .mi condition, any infectious condition,any medication that is a rare condition of the heart Are older
Have a history of heart failure or heart attack
Have blockages (coronary artery disease) in several of your heart's main arteries
Have diabetes or high blood pressure
Are female, Race or ethnicity
Cardiogenic shock signs and symptoms include:
Rapid breathing
Severe shortness of breath
Sudden, rapid heartbeat (tachycardia)
Loss of consciousness
Weak pulse
Low blood pressure (hypotension)
Sweating
Pale skin
Cold hands or feet
Urinating less than normal or not at all
treatment like emergency medication,dopamine ,doputamine ,adrenaline also given as a treatment to the patent. some other surgical procedure is there like cabg , heart transplantationmetc. preventionj oxf this avoid smoking,control alcohol,avoid stress etc
-
Coronary artery disease (CAD) also known as atherosclerotic heart disease, atherosclerotic cardiovascular disease, coronary heart disease, or ischemic heart disease (IHD), is the most common type of heart disease and cause of heart attacks. The disease is caused by plaque building up along the inner walls of the arteries of the heart, which narrows the lumen of arteries and reduces blood flow to the heart.
Cardiogenic shock is a rare condition .in this heart unable to pump an adequate amount of blood flow. types coronary cardiogenic shock and noncoronary cardiogenic shock.causes include any rupture of the in the ventricles .mi condition, any infectious condition,any medication that is a rare condition of the heart Are older
Have a history of heart failure or heart attack
Have blockages (coronary artery disease) in several of your heart's main arteries
Have diabetes or high blood pressure
Are female, Race or ethnicity
Cardiogenic shock signs and symptoms include:
Rapid breathing
Severe shortness of breath
Sudden, rapid heartbeat (tachycardia)
Loss of consciousness
Weak pulse
Low blood pressure (hypotension)
Sweating
Pale skin
Cold hands or feet
Urinating less than normal or not at all
treatment like emergency medication,dopamine ,doputamine ,adrenaline also given as a treatment to the patent. some other surgical procedure is there like cabg , heart transplantationmetc. preventionj oxf this avoid smoking,control alcohol,avoid stress etc
-
Coronary artery disease (CAD) also known as atherosclerotic heart disease, atherosclerotic cardiovascular disease, coronary heart disease, or ischemic heart disease (IHD), is the most common type of heart disease and cause of heart attacks. The disease is caused by plaque building up along the inner walls of the arteries of the heart, which narrows the lumen of arteries and reduces blood flow to the heart.
A myocardial infarction (commonly called a heart attack) is an extremely dangerous condition caused by a lack of blood flow to your heart muscle. The lack of blood flow can occur because of many different factors but is usually related to a blockage in one or more of your heart's arteries.
The medicos PDF app was used to collect this information. I stumbled discovered this amazing app when searching for various slides and books and decided to share it with you all. The Google Play Store has a free version of the app.
Importance for learners:
MBBS/Dental
Nursing
Pharmacy
Microbiology
BPH
MPH
MDS
MD
Ophthalmology
Paramedics
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
2. Introduction
CAD refers to a group of diseases which includes stable angina,
unstable angina, myocardial infarction, and sudden cardiac death.
Also known as ischemic heart disease
It is caused by the narrowing of the large blood vessels that supply
the heart with oxygen. fatty deposits called plaque ( Atherosclerosis )
build up inside the coronary arteries.
3. CAD includes :
Atherosclerosis
Acute Coronary Syndrome (A spectrum of clinical conditions from unstable
angina to ST-elevation MI and sudden cardiac death )
Angina Pectoris
Myocardial Infarction ( STEMI , NSTEMI )
4.
5.
6. Collateral circulation
It is a network of tiny blood vessels, and, under normal conditions, not open.
When the coronary arteries narrow to the point that blood flow to the heart muscle
is limited, collateral vessels may enlarge and become active .
This allows blood to flow around the blocked artery to another artery nearby or to
the same artery past the blockage, protecting the heart tissue from injury.
Two factors contribute to growth and extent of collateral circulation :
•The inherited predisposition of develop new blood vessels ( angiogenesis )
•The presence of chronic ischemia
7.
8.
9.
10.
11. A survey conducted by the Charlotte Housing Authority (CHA) in Charlotte, NC, found
that many public housing residents had risk factors for heart disease, such as high
blood pressure, high cholesterol, diabetes, physical inactivity, overweight/obesity, and
cigarette smoking.
12. Atherosclerosis
It begins as fatty
streaks, lipids that are
deposited in the intima
of the arterial wall
plaques, protrude into
the lumen of the vessel,
narrowing it and
obstructing blood flow .
13. Pathophysiology
Injury to endothelial lining due to various factors like (tobacco use ,hypertension ,
hyperlipidaemia etc. )
Accumulation of lipoproteins in the vessel wall – Mainly LDL
Monocyte adhesion to the endothelium – Followed by migration into the intima and
transformation into macrophages and foam cells.
14. Cont.….
Platelets adhesion takes place at the site of injury
smooth muscles cell proliferation occurs
The proliferation results in deposits, called atheroma's or plaques, which protrude
into the lumen of the vessel, narrowing it and obstructing blood flow .
16. Angina Pectoris
It is a Clinical syndrome characterized by transient episodes of substernal chest
pain or discomfort caused by myocardial ischemia .
Chronic stable angina is the most common manifestation of CAD .
Relieved by Nitroglycerine .
17. Types of Angina
Stable angina
Unstable angina
Intractable or refractory angina
Variant angina
Silent ischemia
18. Characteristics of pain
Location : left-sided or Retrosternal
Radiation : radiating to the left arm, neck, jaw, or back
Duration : 30 sec to 15 min
20. Myocardial infarction (MI) refers to tissue death (infarction) of the heart muscle
(myocardium).
It is a type of acute coronary syndrome, which describes a sudden or short-term
change in symptoms related to blood flow to the heart .
It occurs as a result of thrombotic occlusion of the coronary artery and causes
irreversible cell injury and necrosis .
it may be classified as an :
o ST elevation myocardial infarction (STEMI)
o Non-ST elevation myocardial infarction (NSTEMI) based on the results of an ECG .
21. Classification ( based on location )
Anterior myocardial infarction – results from the occlusion of the left
anterior descending coronary artery .
Inferior and posterior MI – occlusion of the right coronary artery that
supplies these regions .
Lateral MI – occlusion of coronary branches supplying the lateral wall of the
left ventricle . Includes left circumflex branch and diagonal branch of the LAD .
Right ventricular MI - occurs in corelation with inferior MI . Results from
occlusion of the RCA proximal to the marginal branches .
22. Characteristics of pain
Severe, immobilizing chest pain.
Usually described as heaviness, pressure, tightness, burning.
Location : Substernal , Retrosternal or Epigastric .
Radiation : It may radiate to neck, jaw, arm or back .
Duration : Lasts for 20 minutes or more.
23.
24. Killip classification
It was published in 1967
categorizes patients with an acute MI based upon the presence or absence
of simple physical examination findings that suggest LV dysfunction.
The higher the Killip class on presentation, the greater the subsequent
mortality
25.
26. TIMI,S Classification
The Thrombolysis in Myocardial Infarction (TIMI) Score
It is used to determine the likelihood of ischemic events or mortality in
patients with angina or myocardial infarction (STEMI).
27.
28. Complications of MI
Sudden death
Left ventricular aneurysm
Left ventricle failure
Mitral regurgitation
Ventricular septal rupture
Arrhythmias
Heart failure
29. Management of MI
A 12 lead resting ECG should be obtained immediately in patients with ongoing chest pain as
rapidly as possible with in 10 minutes of presentation
Morphine - Reduces pain & anxiety, decreases sympathetic tone, systemic vascular resistance
and oxygen demand . 2–4 mg IV every 5–10 minutes until pain is relieved
Oxygen - 2–4 L/min by nasal cannula to maintain oxygen saturation
Nitro glycerine - Dilates coronary vessels—increase blood flow & reduces systemic vascular
resistance and preload .
Sublingual: sorbitrate 5-10 mg every 5 min, up to 3 doses (If SBP >100 mmHg)
Aspirin - Irreversibly inhibits platelet aggregation, stabilizes plaque and arrests thrombus,
reduces mortality in patients with STEMI .
Dosage: 150-300 mg chewed at presentation, then 150 mg PO OD .
30. Cont..…
β-Blocker - oral beta-blocker therapy should be initiated in the first 24 hours (metoprolol 25-50
mg every 12 hours )
ACE inhibitors - Reduces systemic vascular, resistance and cardiac afterload, also reduce
aldosterone release with consequent reduction of circulating fluid load and lower cardiac preload.
low dose oral administration and increase steadily to achieve a full dose within 24 to 48 hours.
(Captopril 6.2 mg TID, Ramipril 2.5-5mg BD)
Heparin – LMWH , subcutaneous Enoxaparin 1mg/kg BD .
32. Physical Examination
History taking for assessing co morbidity
General appearance and behavior
Vital signs
Skin turgor – cold and clammy
Auscultate for heart sounds – S3 gallop may be present as well as crackles (indicates LV
failure )
Assess for level , location of pain .
Many patients have normal pulse rate and blood pressure within the first hour of STEMI.
Patients with large infarctions have hypotension (SBP <100 mmHg or sinus tachycardia
>100/min)
33. ECG ( Electrocardiography )
ST elevation – indicates infarction
ST depression – indicates ischemia
Q wave presence
T wave inversion
RVMI is diagnosed with ST segment elevation in lead V4R, ST elevation in V1
in the presence of ST elevation in inferior leads .
Posterior ST depression in V1-V2 ( RCA or LCA )
Inferior wall MI - II, III, aVF
34.
35. Stress echocardiography
Patient will exercise on a treadmill or stationary bike while doctor monitors the
blood pressure and heart rhythm .
When heart rate reaches peak levels, doctor will take ultrasound images of
the heart to determine whether heart muscles are getting enough blood and
oxygen while patient exercise .
Provides location and extent of MI
36. Nuclear stress test
It is a nuclear imaging test that shows
how well blood flows into your heart
while you’re exercising or at rest .
Also known as thallium stress test
37. Lipid profile
Fasting lipid profile, including total cholesterol, HDL, triglycerides, and calculated
LDL cholesterol .
A composite of lipid and non lipid risk factors of metabolic origin, called
metabolic syndrome, is another risk factor for CAD.
Metabolic syndrome includes abdominal obesity, an elevated triglyceride level,
low HDL level, elevated blood pressure, and impaired function of insulin .
LDL exerts a harmful effect on the arterial wall and accelerates atherosclerosis
38.
39. Cardiac Markers
CK-MB - increases 3-6 hrs after onset of chest pain, peaks in 12-18 hrs & return
to normal within 3-4 days.
LDH - it increases 14-24 hrs after onset of MI, peak within 48-72 hrs & slowly
return to normal over next 7-14 days .
Cardiac troponin T/ I - increases 7-14 hrs after MI & persists for 5-7 days
42. Coronary Angiography
coronary catheterization is a minimally invasive procedure to access the
coronary circulation and blood filled chambers of the heart using a catheter .
It is performed for both diagnostic and interventional (treatment) purposes
Done under local anaesthesia
43.
44. Nursing Management
Pre procedure :
Before the patient undergoes cardiac catheterization a pre cardiac
catheterization patient teaching plan must be established and initiated .
Explain the procedure to the patient
Alleviate anxiety of the patient
Assess for allergies
complete pre procedure checklist before shifting the patient to lab
check and document the status of peripheral pulses.
45. Post procedure :
Assess the peripheral vascularity of the lower extremities.
monitor vital signs, and distal pulses every 15 min
Maintain the patient on hourly intake and output
Check the puncture site for any signs of bleeding
48. Pharmacological Management
Statins - to help lower cholesterol E. g - Lovastatin , simvastatin block cholesterol
synthesis, lower LDL and triglyceride levels, and increase HDL levels
ACE inhibitors - Reduces systemic vascular, resistance and cardiac afterload .
Captopril 6.25 mg TID.
Nitrates – Nitroglycerine sublingually 5-10 mg every 5 minutes, up to 3 doses (If
SBP > 100 mmHg)
Thrombolytics - The purpose of thrombolytic is to dissolve and lyse the thrombus
allowing blood to flow through the coronary artery again (reperfusion) . E. g -
Aspirin , Clopidogrel , streptokinase
49. Chest pain for longer than 20 minutes, unrelieved by nitroglycerin
ST-segment elevation in at least two leads that face the same area of the heart
Less than 24 hours from onset of pain
Absolute Contraindications
Active bleeding
Known bleeding disorder
History of haemorrhagic stroke
History of intracranial vessel malformation
Recent major surgery or trauma
Uncontrolled hypertension
Pregnancy
Indications for thrombolytics
50. Nursing Considerations
Avoid intramuscular injections.
Monitor for acute dysrhythmias, hypotension, and allergic reaction.
Check for signs and symptoms of bleeding
Treat major bleeding by discontinuing thrombolytic therapy
Treat minor bleeding by applying direct pressure if accessible
52. PTCA
Coronary balloon angioplasty, also referred to as percutaneous
(through the skin) coronary intervention (PCI) .
The purpose of PTCA is to improve blood flow within a coronary
artery by “cracking” the atheroma .
The coronary arteries are examined by angiography
53.
54. Risk and complications :
Embolization
Arterial rupture
Hematoma or pseudo aneurysm formation at the access site
Radiation Injuries Radiation induced injuries (burns) from the X-Rays used .
55. Coronary Artery Bypass Grafting
It is a surgical procedure to restore normal blood flow to an obstructed
coronary artery .
The 2004 AHA CABG guidelines state CABG is the preferred treatment for:
• Disease of the left main coronary artery (LMCA).
• Disease of all three coronary arteries (LAD, LCX and RCA).
• Diffuse disease not amenable to treatment with a PCI .
56.
57. Nursing Management
Acute Pain related to Decreased myocardial blood flow Increased cardiac
workload/oxygen consumption .
Risk for Decreased Cardiac Output
Impaired gas exchange related to trauma of extensive chest surgery
Risk for deficient fluid volume and electrolyte imbalance related to alterations
in blood volume
Acute pain related to surgical trauma and pleural irritation caused by chest
tubes and/or internal mammary artery dissection